Understanding the role of video direct observed therapy for patients on an oral short-course regimen for multi-drug resistant tuberculosis: findings from a qualitative study in Eswatini

Author:

Mukooza Esther,Schausberger Bernadette,Mmema Nqobile,Dlamini Velibanti,Aung Aung,Kerschberger Bernhard,Ciglenecki Iza,Vambe Debrah,Wringe Alison

Abstract

Abstract Background Improving treatment success rates among multi drug-resistant tuberculosis (MDR-TB) patients is critical to reducing its incidence and mortality, but adherence poses an important challenge. Video-based direct observed therapy (vDOT) may provide adherence benefits, while addressing the time and cost burden associated with community treatment supporter (CTS)-DOT. This study explored experiences of patients, family members and healthcare workers with different DOT modalities for adherence support in Eswatini. Methods Between April 2021 and May 2022, thirteen men and five women with MDR-TB, ten healthcare workers, and nine caregivers were purposively sampled to include a range of characteristics and experiences with DOT modalities. Data were generated through individual in-depth interviews and a smartphone messaging application (WhatsApp). Data coding was undertaken iteratively, and thematic analysis undertaken, supported by Nvivo. Results Four themes emerged that reflected participants’ experiences with different DOT modalities, including stigma, efficiency, perceived risks of TB acquisition, and patient autonomy. vDOT was appreciated by patients for providing them with privacy and shielding them from stigmatisation associated with being seen in TB clinics or with community treatment supporters. vDOT was also seen as more efficient than CTS-DOT. Health workers acknowledged that it saved time, allowing them to attend to more patients, while many patients found vDOT more convenient and less expensive by removing the need to travel for in-person consultations. Health workers also appreciated vDOT because it reduced risks of TB acquisition by minimising exposure through virtual patient monitoring. Although many patients appreciated greater autonomy in managing their illness through vDOT, others preferred human contact or struggled with making video recordings. Most family members appreciated vDOT, although some resented feeling removed from the process of supporting loved ones. Conclusions vDOT was generally appreciated by MDR-TB patients, their family members and health workers as it addressed barriers to adherence which could contribute to improved treatment completion rates and reduced workplace exposure. However, patients should be offered an alternative to vDOT such as CTS-DOT if this modality does not suit their circumstances or preferences.

Funder

Mèdecins Sans Frontiéres, Switzerland

Publisher

Springer Science and Business Media LLC

Reference35 articles.

1. WHO. Global Tuberculosis Report 2022. Accessed: Mar. 02, 2023. [Online]. Available: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022

2. WHO. Global tuberculosis report: Country, regional and global profiles. Accessed: Mar. 14, 2024. [Online]. Available: https://www.who.int/teams/global-tuberculosis-programme/data

3. Ministry of Health, Eswatini. National Tuberculosis Programme. Accessed: Mar. 06, 2023. [Online]. Available: https://www.gov.sz/index.php/departments-sp-654042511?id=471

4. Kerschberger B, et al. Successful expansion of community-based drug-resistant TB care in rural Eswatini – a retrospective cohort study. Trop Med Int Health. 2019;24(10):1243–58. https://doi.org/10.1111/tmi.13299.

5. World Health Organization, Guidelines for treatment of drug-susceptible tuberculosis and patient care. 2017 update. Geneva: World Health Organization, 2017. Accessed: Mar. 19, 2024. [Online]. Available: https://iris.who.int/handle/10665/255052

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3